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Most studies evaluating lymphoedema treatment effect focus on objective reductions in limb 
volume, with little attention given to subjective treatment outcomes. The objective of this 
work was to describe the range of lymphoedema symptoms experienced by patients and the 
importance of symptom improvement following treatment. The second aim was to explore 
lymphoedema treatment use and the effect of individual treatments on symptoms, from the 
patient’s perspective. Australian adults with lymphoedema (n=421) completed a self-
administered questionnaire. Information was collected about patients’ symptoms, the 
importance of symptom improvement following treatment, as well as treatment types used 
and perceived effectiveness of each treatment. In addition to swelling, the vast majority of 
participants experienced heaviness and tightness in the affected region. Overall, symptoms of 
lymphoedema varied between individuals but the majority considered subjective symptom 
improvement to be an important outcome of treatment. The most commonly used treatments 
were compression garments, self-massage, prescribed exercises and manual lymph drainage, 
and the majority (95%) of participants had used multiple treatments to manage their 
lymphoedema. The impact of treatments on subjective symptoms varies widely between 
treatments. Consequently, in addition to objective measures of swelling, it is important to 
include patient-reported outcomes in future prospective lymphoedema treatment studies.  
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Introduction  
Lymphoedema is characterised by impaired drainage of lymphatic fluid, resulting in swelling 
and a range of other physical symptoms, including heaviness, tightness, pain and numbness [1, 
2]. Primary lymphoedema develops due to an inherited abnormality in the lymphatic system, 
while secondary lymphoedema is caused by trauma or injury [2]. Worldwide, the most common 
cause of secondary lymphoedema is the parasitic infection filiarisis, while in developed 
countries the primary cause of secondary lymphoedema is cancer treatment [3]. It is among the 
most feared complications following cancer treatment [4] and in many cases has significant 
physical, psychological and social implications [5–7]. Individual experiences of lymphoedema 
vary, with some experiencing acute onset and relief of symptoms and others developing a 
chronic condition [8, 9]. While some people are prone to exacerbations resulting in severe 
swelling and skin infections, others have relatively stable symptoms.  
Regardless of the etiology, the methods used to treat the condition are the same. Conservative 
treatments are initially prescribed, with surgical options considered when patients no longer 
respond to conservative options [10]. Although high quality evidence to support lymphoedema 
treatment guidelines is limited [3, 11, 12], treatments including complex physical therapy 
(CPT), manual lymph drainage (MLD), compression (bandages, garments and pneumatic 
compression pumps), low-level laser and exercise, are the most widely prescribed forms of 
lymphoedema [13, 14]. Complex physical therapy (also called complex decongestive therapy) 
consists of two phases, a treatment phase followed by a maintenance phase, and combines four 
lymphoedema treatment strategies; manual lymph drainage, compression, skin care and limb 
exercises [15]. Many of these treatments require considerable commitment from patients, in 
terms of the financial costs, time and effort involved. In addition, many people with 
lymphoedema require assistance from another person to perform self-management components 
of their treatment.  
Long term treatment success is likely to be influenced by adherence to treatment [16] but little 
attention has been given to patients’ experiences of treatment. Most studies of treatment effect 
focus on objective reductions in limb volume only. While these are important outcome 
measures in intervention studies, less attention has been paid to other symptoms of 
lymphoedema, and to whether treatments have any effects on these. This represents an 
important gap in the literature since previous studies have reported no associations between 
limb volume and quality of life, but quality of life detriments are evident in highly symptomatic 
patients [17–21]. This study aimed to determine the range of symptoms experienced by people 
with lymphoedema and the importance of symptom improvement as a treatment outcome. An 
additional aim was to describe patients’ treatment use and perspectives of treatment effect for 
alleviating the range of lymphoedema symptoms experienced.  
Methods  
This cross-sectional study recruited a convenience sample of people with lymphoedema. 
Following ethical approval by the Queensland University of Technology Human Research 
Ethics Committee, participants were approached for the study through the Lymphoedema 
Association of Queensland (LAQ), the Lymphoedema Association of Victoria and an 
International Society of Lymphology patient information session in Sydney, Australia. Self-
administered questionnaires were sent to 1030 members of the associations. Approximately 43% 
(n=441) completed and returned the questionnaire. However, a further 20 participants were 
excluded as they did not meet the eligibility criteria of being 18 years or over, with diagnosed 
lymphoedema. Consequently, data from 421 participants was included in analyses. 
Self-administered questionnaire: 
Patients indicated whether or not they had experienced ten possible lymphoedema symptoms, 
including swelling, heaviness, tightness, aching, tenderness, stiffness, weakness, numbness, 
pain and range of movement. The symptoms included were determined by those most often 
identified in the literature [22] and through consultation with people with lymphoedema and 
an experienced lymphoedema physiotherapist and researcher. Participants were asked whether 
they considered improvements in each physical symptom an important outcome of treatment 
using a likert-scale with 5 categories ranging from not important at all to very important. 
To determine the extent of mainstream treatment use, participants were asked to indicate which 
treatments they had ever used to treat their lymphoedema. Mainstream treatments were 
determined by those regularly prescribed by health professionals in a study conducted by 
Langbecker et al. (2008) and included CPT, MLD, compression garments, bandages and pumps, 
prescribed exercises, self-massage, laser therapy. Surgery was also included as it has become 
more commonly used in recent years. Perceived effectiveness of each form of treatment was 
measured for all 10 lymphoedema symptoms by asking participants to indicate whether for 
each of the treatments they had used , it helped each symptom “very little/little” 
“somewhat/moderately” or “quite a lot/very much”. In addition, participants were invited to 
provide any additional information about their symptom or treatment experience in an open-
ended question. 
The questionnaire also collected information on demographic characteristics including age, 
gender, marital and parental status, living arrangements and socioeconomic status (as defined 
by education level, employment status, private health insurance and income). Information 
relating to lymphoedema location, duration and characterisation (single episode, recurrent or 
persistent) was assessed separately for each limb segment, as well as the groin and trunk. 
Statistical analysis: 
Descriptive statistics (means, standard deviations and proportions) were used to describe 
personal and lymphoedema characteristics of the sample. Frequencies of symptoms and 
mainstream treatment options were computed to determine their prevalence. Counts and 
proportions were used to describe the importance of improvement in symptoms and other 
lymphoedema-associated outcomes, as well as perceived effectiveness for 10 different 
symptoms. All available data were used, resulting in different numbers of participants across 
treatments and symptoms. The relevant numbers of participants contributing to each outcome 
are provided in all tables. Data analyses were performed using SPSS version 18.  
Results  
Participant characteristics 
The majority of participants were 55 years or older, with a median age of 66.0 years (min=18.0, 
max=91.0), and most (95%) were female. Approximately half of the participants lived with 
partners, friends or relatives (52%), and around 10% had children living at home. Just over 40% 
had education levels of Year 12 completion or less, and 44% had annual household incomes 
below $52,000. More than three quarters of participants had private health insurance (77%). 
The majority of participants had secondary lymphoedema (78%) and of these, most had 
developed lymphoedema following cancer treatment (83%). Among those who had developed 
lymphoedema following cancer, 70% had been diagnosed with breast cancer, 16% had 
gynaecological cancer and 14% had other cancer types. Similar proportions of participants had 
upper-limb lymphoedema (ULL, 46%) and lower-limb lymphoedema (LLL, 43%) and 11% 
had symptoms affecting multiple areas of the body. The majority of participants had 
lymphoedema for more than 3 months (84%), and described their lymphoedema as ‘persistent’ 
(78%).  
Lymphoedema symptoms 
In addition to swelling (reported by 99% of participants), the vast majority of participants 
(89%) experienced heaviness and/or tightness (Table 1) as a symptom of lymphoedema. Over 
75% experienced aching and/or indicated they had reduced range of movement in the 
affected limb. More than half of all participants had experienced each individual symptom.  
Importance of improvement in symptoms following treatment 
Of the 10 lymphoedema symptoms queried, more than 60% of those with swelling, heaviness, 
tightness and reduced range of movement reported improvements in those symptoms following 
treatment as being very important. No less than 40% of participants who had each symptom 
said improvements in that symptom were very important outcomes of treatment.  
Treatment use 
At least two-thirds of participants had used compression garments (86%), self-massage (79%), 
prescribed exercises (69%), or MLD (67%) to treat their lymphoedema (Table 2). In addition, 
compression bandaging and/or CPT were used by 45% and 42% of participants, respectively. 
Between 3 and 18% had used laser therapy, pneumatic compression pumps (PCP), and/or had 
surgery to treat their lymphoedema (18%, 12%, 3%, respectively). Over half (62%) of all 
participants had used more than four lymphoedema treatment types, while 5% had used only one 
type of lymphoedema treatment. 
Perceived effectiveness of lymphoedema treatment types 
Regardless of the treatment used, at least one in five, and up to 60% of participants (who 
experienced each symptom) perceived their lymphoedema treatment (regardless of treatment 
type) as effective in treating their swelling (26 to 60% across treatment types), heaviness (23 
to 50%), tightness (23 to 52%), and aching (20 to 40%) (Fig. 1). Lower proportions of 
participants reported improvements in weakness, numbness and pain (median proportions 
<20%) following any type of treatment.  
Responses to the open-ended question about lymphoedema and associated treatment 
highlighted that, in some cases, the success of treatment was due to a combination of strategies 
being used. The quotes below provide additional insight; 
“After original diagnosis and treatment, the pain, movement and general wellbeing 
improved greatly. Compression garment worn every day for years. Exercises and 
hydrotherapy kept me mobile and virtually pain free.”  
“I am currently using a range of treatments. Between them, they seem to give me some 
overall relief and help to prevent my lymphoedema from becoming worse. No one 
treatment on its own would achieve this.” 
 
Proportions of patients who experienced each symptom and who found their treatment effective 
for improving their symptoms are presented in Table 3. Across all symptoms, CPT, 
compression garments, compression bandaging and MLD were perceived as effective at 
improving a range of lymphoedema symptoms by the highest proportions of participants. For 
each symptom, 18 to 60% of participants reporting improvements following each of these 
treatments (shaded in Table 3). By comparison, self-administered massage and prescribed 
exercises consistently had the lowest proportions of participants reporting the treatments as 
effective at improving symptoms. 
When considering individual symptoms, some treatments were reported by higher proportions 
of participants as improving specific symptoms, with less effect on others (Table 3). For 
example, almost half of all participants who had used laser therapy (47%) reported 
improvements in tightness. Subjective improvements in swelling, the most common symptom 
of lymphoedema, were reported by at least one in two participants who used compression 
garments, CPT, compression bandaging, and/or surgery to treat their lymphoedema (60%, 60%, 
52% and 50%, respectively).  
Improvements in swelling, heaviness, tightness and range of movement were considered very 
important treatment outcomes by at least 60% of participants. Improvements in these symptoms 
following treatment are presented in Figure 2, and were reported by the highest proportion of 
participants following the use of CPT. While 40-60% of participants who used compression 
garments also reported improvements in swelling, heaviness and tightness, improvements in 
range of movement were reported by less than 25% of those who used garments (Fig. 2).  
Responses to the open-ended question confirmed participants felt compression garments, in 
particular, were an important part of maintaining symptom improvements in the longer term, 
as described below.  
 “I have learnt to live with the fact that I cannot go without wearing my 
compression garments.” 
 “I was diagnosed very soon after my operation and received treatment straight 
away. Early on I did recommended exercises daily also, but found the garments kept 
the condition under control.” 
Discussion  
A range of treatments are commonly prescribed for patients with lymphoedema, with varying 
scientific evidence to support their use [3, 11, 12, 23, 24]. Studies investigating treatment effect 
typically measure limb size before and after a program of treatment. However, findings from 
previous studies have found that quality of life is not associated with limb size [17, 20, 21, 25, 
26]. It is plausible other symptoms of lymphoedema have greater impact on quality of life and 
reported improvements following treatment [18, 20, 27, 28] are due to improvements in 
lymphoedema symptoms, beyond measurable changes in swelling.  
This study confirmed that patients’ experiences of lymphoedema, associated symptoms and 
effect of treatments to alleviate these symptoms vary widely. Almost all participants reported 
swelling at the time of completing the study, and 89% also experienced heaviness and/or 
tightness of the affected area. Interestingly, while pain is not typically considered a common 
symptom of lymphoedema and is rarely documented in studies of lymphoedema treatment [27], 
65% of participants in the current study reported experiencing pain. The vast majority of people 
with lymphoedema felt symptom improvement, beyond objective reductions in swelling, were 
important outcomes of treatment. Improvements in swelling, heaviness, tightness and range of 
movement were reported as ‘very important’ or ‘important’ treatment outcomes by nine of 10 
participants. Of those who experienced pain, over 80% felt reduced pain following treatment 
was a ‘very important’ or ‘important’ treatment outcome. These findings add to those from 
previous studies that have suggested increased function, softening of tissues, reduced shape 
distortion and reducing likelihood of infection may be as equally important to patients as 
reductions in limb volume [29, 30]. 
People with lymphoedema use a range of treatments to manage their symptoms. In the current 
study, treatments reported by higher proportions of participants, including compression 
garments, self-massage, exercises and MLD, were in line with the most commonly prescribed 
treatments by health professionals, reported by Langbecker et al. [13]. However, fewer 
participants in the current study reported using compression bandaging (45%) when compared 
with the proportion of health professionals who prescribed compression bandaging (72%) for 
their patients with lymphoedema [13]. While treatment use in this study was similar to findings 
from an Australian study of women with breast cancer-related lymphoedema [31], there were 
some noteworthy differences when compared with findings from a population-based study in 
the UK. For example, MLD was used by 67% and 4%, and self-massage by 79% and 17% of 
study participants, respectively. This could be due to differences in participants recruited by 
purposeful sampling versus population-based sampling, or may indicate different prescribing 
practices in Australia compared with the UK. Understanding the differences in treatment use 
is important as it may suggest location- or population-specific barriers to treatment requiring 
particular attention.   
Findings from randomised, controlled trials support the use of compression therapy to treat 
lymphoedema, with reductions in limb volume and/or circumferences reported following the 
use of compression garments and bandages alone, and greater reductions reported when 
compression was combined with other physical therapies [11, 12, 14]. Results from the current 
study confirmed compression garments and bandages were also perceived by people with 
lymphoedema to improve a range of other lymphoedema symptoms, including heaviness and 
tightness. The scientific evidence to support other treatment modalities is limited but findings 
from this study suggest only some patients experience improvements in lymphoedema 
following their use. Improvements in individual symptoms were measured in this study as it 
was considered possible that a treatment which improved pain or numbness without having a 
significant impact on limb volume could still be considered as valuable and important as a 
treatment which has proven effective in reducing limb size. Although the effects of pneumatic 
compression pumps, MLD, laser therapy and prescribed exercises have been inconsistent when 
considering limb size as the primary treatment outcome [12, 32, 33], many participants in this 
study reported positive effects of these treatments on a range of symptoms. For example, 
compression pumps were reported as effective for improving stiffness and range of movement 
by higher proportions than other types of compression. Similarly, MLD and laser therapy were 
reported as improving tightness by over 40% of participants who used these treatments and 
experienced tightness. In addition, around one in four participants who used exercises reported 
improvements in swelling, heaviness, tightness and range of movement. These findings provide 
important information for health professionals treating patients who may want assistance with 
managing specific symptoms. 
A difficulty with investigating treatment outcomes for lymphoedema is that patients often use 
multiple treatments concurrently, making it impossible to determine the individual contribution 
of treatments for symptom relief. However, the quantitative and qualitative data collected from 
this study suggest that people use multiple treatments to improve different symptoms and that 
overall, better subjective outcomes are achieved when treatments are combined. Incorporating 
patient-reported outcomes into descriptive or intervention studies where treatment protocols 
are carefully defined, controlled or monitored could help to identify direct effects of different 
treatments on symptoms.  
While this study included people with primary and secondary lymphoedema, men were 
unrepresented and the convenience sampling approach may limit the representativeness of the 
sample to the wider lymphoedema population. As members of support organisations, 
participants may have experienced more symptoms and sought access to a wider range of 
treatments than those with lymphoedema in the general population. The study design was 
cross-sectional, with participants needing to recall perceptions about treatments they may not 
have been currently using, potentially introducing recall bias. Nonetheless, this study is the 
first to explore the effect of available lymphoedema treatments on 10 individual symptoms 
from the patient’s perspective and provides valuable information to be incorporated in future 
longitudinal studies of treatment effect and adherence.  
The symptoms of lymphoedema can have a significant impact on physical function and 
mobility, as well as social and psychological implications. Findings from this study suggest 
treatments found to reduce limb volume in previous studies, including CPT and compression 
therapy, are also effective for improving a range of other physical symptoms. In addition, a 
number of treatments that currently lack a scientific evidence base were reported to improve 
participants’ objective symptoms. For people with multiple, chronic symptoms of 
lymphoedema, there is no single treatment currently regarded as a ‘gold standard’ and 
combining treatments may be necessary to manage symptoms effectively. Findings from this 
study highlight the need to consider patient-reported measures in addition to measures of limb 
volume in future intervention research. It is important for researchers, health care services and 
health professionals to consider individual circumstances and responses to treatment to 
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Swelling 418 (99.3) 301 (72.0) 83 (19.9) 37 (8.1)
Heaviness 375 (89.1) 236 (62.9) 93 (24.8) 92 (12.3)
Tightness 375 (89.1) 225 (60.0) 97 (25.9) 99 (14.1)
Reduced range of 
movement 
328 (77.9) 209 (63.7) 68 (20.7) 144 (15.5)
Aching 323 (76.7) 183 (56.7) 88 (27.2) 150 (16.1)
Tenderness 286 (67.9) 140 (49.0) 76 (26.6) 205 (24.5)
Pain 275 (65.3) 157 (57.1) 68 (24.7) 196 (18.2)
Stiffness 261 (62.0) 134 (51.3) 71 (27.2) 216 (21.5)
Weakness 254 (60.3) 112 (44.1) 67 (26.4) 242 (29.5)
Numbness 225 (53.4) 101 (44.9) 56 (24.9) 264 (30.2)





Table 2. Use of mainstream treatment options by people with lymphoedema (n=421) 
Treatment n (%) 
Compression garment 362 (86.0) 
Self-massage 332 (78.9) 
Prescribed exercises 291 (69.1) 
Manual Lymph Drainage 285 (67.3) 
Compression bandaging 188 (44.7) 
Complex Physical Therapy 176 (41.8) 
Laser Therapy 77 (18.3) 
Pneumatic Pumps 51 (12.1) 
Surgery 14 (3.3) 
 





















CG CPT CPT CPT CPT CPT CPT CPT CG CPT
216 (60.0) 83 (50.3) 86 (51.5) 60 (40.5) 41 (31.3) 41 (33.1) 25 (20.7) 27 (25.5) 63 (26.7) 53 (35.6)
CPT CB LAS CG CG PCP CG MLD MLD SURG
105 (59.7) 79 (46.7) 34 (46.6) 108 (38.7) 74 (29.7) 11 (32.4) 44 (19.7) 35 (21.6) 53 (26.4) 4 (30.0)
CB CG CB MLD MLD SURG CB CB CPT PCP
98 (52.1) 153 (46.6) 78 (44.6) 88 (38.4) 57 (27.5) 3 (30.0) 23 (18.4) 21 (19.8) 30 (23.3) 14 (29.8)
SURG MLD CG CB CB MLD MLD CG CB CB
7 (50.0) 109 (41.6) 138 (42.9) 51 (32.1) 32 (23.2) 53 (27.6) 34 (18.0) 36 (18.7) 30 (22.9) 44 (27.3)
MLD SURG MLD LAS LAS CB PCP PCP LAS MLD
132 (46.2) 5 (38.5) 112 (42.3) 19 (28.8) 13 (23.2) 31 (24.8) 5 (14.7) 6 (18.2) 12 (20.3) 61 (26.6)
PCP LAS SURG SURG SURG LAS PE SURG SURG PE
22 (43.1) 22 (30.6) 5 (35.7) 3 (27.3) 2 (20.0) 13 (23.6) 26 (14.0) 1 (14.3) 2 (20.0) 58 (24.6)
LAS PCP PCP PCP PCP CG SURG LAS PCP CG
27 (35.1) 15 (30.6) 16 (32.0) 12 (26.1) 8 (19.0) 51 (22.5) 1 (12.5) 6 (13.0) 7 (18.4) 69 (23.8)
PE PE PE PE PE PE SAM SAM PE LAS
78 (26.9) 64 (24.3) 65 (24.3) 50 (21.9) 30 (15.1) 43 (22.5) 22 (10.2) 24 (12.6) 33 (16.6) 14 (21.2)
SAM SAM SAM SAM SAM SAM LAS PE SAM SAM
86 (26.1) 71 (23.4) 71 (23.2) 53 (20.0) 34 (14.6) 25 (11.3) 5 (9.8) 18 (11.0) 33 (14.3) 38 (14.1)
Shading highlights the four treatments for which the highest proportions of participants reported improvements in symptoms; aProportions 
of patients who used the treatment and had the symptom; RoM – Range of movement CG – Compression garments; CPT – Complex physical 
therapy; CB – Compression bandaging; SURG – Surgery; MLD – Manual lymph drainage; PCP – Pneumatic compression pumps; LAS – 
Laser therapy; PE – Prescribed exercises; SAM – Self-administered massage 
 Fig. 1 Box plot of the proportions of participants who reported improvements in symptoms 
following any type of lymphoedema treatment. Boxes represent median (and interquartile 




 Fig. 2 Proportions of participants with each symptom who reported improvements in swelling, 
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